Article Details
Retrieved on: 2024-04-16 20:58:31
Tags for this article:
Click the tags to see associated articles and topics
Summary
Somite, an AI biotech company, raised $5.3M to advance its AlphaStem AI platform, which aims to create human tissue for cell therapies, leveraging techniques like RNA sequencing and digital twin technology to model embryonic development.
Article found on: www.finsmes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here